RAC 2.20% $1.78 race oncology ltd

General Comments / Chat, page-7788

  1. 1,881 Posts.
    lightbulb Created with Sketch. 470
    The fact of the matter is DCB is out there pumping the stock in the face of 1) significant macro headwinds which are affecting most biotechs 2) Dr T departure/RAC board changes which have undermined some investors confidence 3) tax loss selling season and 4) in the absence of any recent new data/announcements to base his pumping on.The market is punishing RAC in this environment. Nothing will change without a change to some or all of those things, particularly point 4 in my view.

    Success begets success, and RAC have not tabled a lot recently and lost momentum. Without new evidence, his meetings and tweets are just noise at this point in time in my view. I know that sounds harsh, and he needs to start somewhere, but without evidence I can't see us getting any traction.

    I hope JabraD on the chart thread is wrong. I really want RAC to succeed, but the further the SP slides the further we have to climb back up (unless it is a straight out buyout).

    Cheers
    kk
    PS Bring back the buyback
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.